Tuesday, March 24, 2026 at 4:00 PM Eastern Time / 3:00 PM Pacific Time
Speaker:
Dr. Gil Wolfe
Description:
- Join us for a webinar to learn about telitacicept, an investigational treatment being studied for patients with gMG. You will discover:
- How telitacicept works in a different way from other current therapies by targeting key immune signaling proteins that play a part in the production of MG-causing antibodies
- Available data from clinical studies of telitacicept in patients with gMG
Details around an ongoing, currently enrolling global clinical trial of telitacicept in patients with gMG that includes study sites in the US
Sponsored by VOR
Register
After registering, you will receive a confirmation email containing information about joining the webinar.